Translational control: A target for cancer therapy
Authors:
- Robert A. KratzkeRKRobert A. Kratzke
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 258 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- High eIF4E, VEGF, and Microvessel Density in Stage I to III Breast CancerAnnals of Surgery, 2006
- Repression of Cap-Dependent Translation Attenuates the Transformed Phenotype in Non–Small Cell Lung Cancer Both In vitro and In vivoCancer Research, 2006
- Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosisLeukemia & Lymphoma, 2006
- A Prospective Trial on Initiation Factor 4E (eIF4E) Overexpression and Cancer Recurrence in Node-Positive Breast CancerAnnals of Surgery, 2005
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004
- The role of c-myc in regulation of translation initiationOncogene, 2004
- Rapamycin is an effective inhibitor of human renal cancer metastasis11See Editorial by Sukhatme and Strom, p. 1160.Kidney International, 2003
- Expression of eIF4E During Head and Neck Tumorigenesis: Possible Role in AngiogenesisThe Laryngoscope, 1999
- Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinomaCancer, 1997
- Translational Control of Protein SynthesisAnnual Review of Biochemistry, 1976